You need to be logged in to view this video

Finding Year End Biotech Bargains in Tax Loss Selling Season

Released on Tuesday, December 7, 2021•BIOTECH

Share
Facebook Twitter LinkedIn SMS

Tax loss selling in December offers oversold biotechs that will bounce nicely into the new year, creating what is known as the "January Effect."

John McCamant

Medical Technology Stock Letter, Editor

John McCamant joined the leading investment newsletter, Medical Technology Stock Letter, as an associate editor in 1987 and was named editor in August 2000. He has spent over 35 years on the front lines of biotechnology investing. In his previous role as an equities analyst for the American Healthcare fund, Mr. McCamant uncovered investment opportunities and guided investment strategy.